Literature DB >> 8162481

A district audit on the management of polymyalgia rheumatica and giant cell arteritis.

K Chakravarty1, S H Elgabani, D G Scott, P Merry.   

Abstract

Twenty-one hospital consultants, representing 20% of the hospital specialists and 54 general practitioners representing 22% of the general practitioners in the Norwich Health District were circulated a questionnaire on the management of polymyalgia rheumatica and giant cell arteritis, as part of a departmental audit. The wide variations in the diagnosis and treatment of these two common conditions are shown in this study. Appropriate recommendations have been made for these two common conditions in the hope of providing a useful guideline for more uniform and effective therapy. We intend to repeat this study at a later date to assess if any of the recommendations have been undertaken successfully.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162481     DOI: 10.1093/rheumatology/33.2.152

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  6 in total

1.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

2.  The epidemiology of polymyalgia rheumatica in primary care: a research protocol.

Authors:  Sara Muller; Samantha Hider; Toby Helliwell; Joanne Bailey; Kevin Barraclough; Louise Cope; Bhaskar Dasgupta; Rebecca Foskett; Rhian Hughes; Zoe Mayson; Charlotte Purcell; Edward Roddy; Simon Wathall; Irena Zwierska; Christian D Mallen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-15       Impact factor: 2.362

3.  2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Bhaskar Dasgupta; Marco A Cimmino; Hilal Maradit-Kremers; Wolfgang A Schmidt; Michael Schirmer; Carlo Salvarani; Artur Bachta; Christian Dejaco; Christina Duftner; Hanne Slott Jensen; Pierre Duhaut; Gyula Poór; Novák Pál Kaposi; Peter Mandl; Peter V Balint; Zsuzsa Schmidt; Annamaria Iagnocco; Carlotta Nannini; Fabrizio Cantini; Pierluigi Macchioni; Nicolò Pipitone; Montserrat Del Amo; Georgina Espígol-Frigolé; Maria C Cid; Víctor M Martínez-Taboada; Elisabeth Nordborg; Haner Direskeneli; Sibel Zehra Aydin; Khalid Ahmed; Brian Hazleman; Barbara Silverman; Colin Pease; Richard J Wakefield; Raashid Luqmani; Andy Abril; Clement J Michet; Ralph Marcus; Neil J Gonter; Mehrdad Maz; Rickey E Carter; Cynthia S Crowson; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-04       Impact factor: 19.103

4.  The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan.

Authors:  Toshikatsu Okumura; Satoshi Tanno; Masumi Ohhira; Tsukasa Nozu
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

5.  Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice.

Authors:  Toby Helliwell; Samantha Lara Hider; Christian David Mallen
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

6.  Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica.

Authors:  Parthajit Das; Ash Samanta; Bhaskar Dasgupta
Journal:  RMD Open       Date:  2015-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.